top of page
Ganciclovir for Injection

Ganciclovir for Injection

What is Ganciclovir for Injection?

Ganciclovir for Injection is a potent antiviral medication belonging to the nucleoside analogue class. It is specifically designed to inhibit the replication of the Cytomegalovirus (CMV), a member of the herpesvirus family. It is a critical treatment for immunocompromised patients, such as those with HIV/AIDS or organ transplant recipients, who are at high risk for vision loss or systemic organ damage due to CMV.

Uses of Ganciclovir for Injection

  • CMV Retinitis: Treatment of life-threatening or sight-threatening CMV infection of the retina.

  • CMV Prevention: Prophylaxis of CMV disease in transplant recipients at risk for the infection.

  • Systemic CMV Infections: Management of CMV-related pneumonia, colitis, or esophagitis.

  • HIV/AIDS Complications: Long-term maintenance treatment to prevent recurrence of CMV retinitis.

  • Congenital CMV: In specific neonatal cases to prevent hearing loss or developmental issues (under strict supervision).

How Does Ganciclovir for Injection Work?

Ganciclovir works by being converted into ganciclovir triphosphate inside virus-infected cells. This active form competes with deoxyguanosine triphosphate for incorporation into the viral DNA. Once incorporated, it terminates the elongation of the viral DNA strand, effectively stopping the virus from replicating and spreading to healthy cells.

FAQs on Ganciclovir for Injection

1. How is Ganciclovir for Injection administered? Ganciclovir must be administered via slow intravenous (IV) infusion over a period of one hour. It should never be given as a rapid or "bolus" injection because this increases the risk of toxicity and kidney damage.

2. Why is Ganciclovir considered a critical drug for transplant patients? Transplant patients take immunosuppressants to prevent organ rejection, which makes them highly vulnerable to "opportunistic" infections like CMV. Ganciclovir is used both to treat active infections and as a preventive measure (prophylaxis) to ensure the success of the transplant.

3. What are the common side effects to monitor? The most significant side effects involve the blood, specifically a decrease in white blood cells (neutropenia) and platelets (thrombocytopenia). Regular blood counts are necessary during treatment to monitor for bone marrow suppression.

Therapeutic Category

Anti-Infectives (Antiviral)

Looking for a reliable Ganciclovir for Injection manufacturer? Contact Farbe Firma Pvt. Ltd. for dossier support, registration assistance, and export supplies. We provide high-quality sterile injectables compliant with international regulatory standards.

  • Product Name

    Ganciclovir for Injection

  • Trade Name

    Gancisyl

  • Available Strength

    500 mg

  • Packing

    Lyo Vial

  • Therapeutic Use

    Treatment of Cytomegalovirus (CMV) infections

Productos relacionados

Sobre Nosotros
Farbe Firma Pvt. Ltd. es un fabricante de inyectables estériles certificado por OMS-GMP, que ofrece CDMO, fabricación por contrato y soluciones de suministro farmacéutico global.

  • Threads
  • X
  • FB
  • LinkedIn
  • Insta
  • Whatsapp
  • Xing
  • Youtube

ALCANCE GLOBAL

• Región de África
• Región de Asia-Pacífico
• Región de Medio Oriente y CCG
• Región de América Latina y el Caribe
• Región de la CEI y Asia Central

  • Programa de Socios

  • Preguntas Frecuentes (FAQ)

  • Resultados de Búsqueda

  • Carreras

  • Política de Privacidad

  • Términos y Condiciones

PRODUCTOS PRINCIPALES

Inyección de Pantoprazol

Emulsión inyectable de Propofol

Inyección de Sacarosa Férrica

Inyección de Glutatión

Inyección de Carboximaltosa Férrica

Agua Bacteriostática para Inyección

Agua para Inyección

Inyección de Cloruro de Sodio

Inyección de Gadoterato de Meglumina

Inyección de Paracetamol

Inyección de Emulsión Grasa

© 2026 Farbe Firma Pvt. Ltd. Todos los derechos reservados.

bottom of page